Skip to Content

'Vaccine Passports' to Be Part of Britain's Reopening Plan

MONDAY, April 5, 2021 -- A pilot project involving "vaccine passports" will be among the measures included in the British government's plan to fully reopen the economy as it continues to struggle with the COVID-19 pandemic.

Other proposals in the plan expected to be unveiled Monday include frequent mass testing with at-home test kits, according to British media. British authorities plan to make the tests available to residents on a twice-weekly basis. Critics, however, have said that the rapid tests, which provide results in about 30 minutes, are flawed and should not be relied on to tame the pandemic.

The proposed vaccine passports, or "coronavirus status certifications," would show whether a person has been vaccinated, recently tested negative for the COVID19, or has natural immunity due to previous infection within the last six months, The Washington Post reported.

However, the measure is likely to be controversial. It would require parliamentary approval, and 70 MPs recently started a campaign to oppose COVID-19 certifications.

The Washington Post Article

© 2021 HealthDay. All rights reserved.

Read this next

Response to One COVID-19 Vaccine Dose Strong in Previously Infected

FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...

Booster Shots a Likely Reality for COVID-19-Vaccinated Americans

FRIDAY, April 16, 2021 -- Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer said...

Hemorrhagic Stroke + COVID-19 Doubles Risk for In-Hospital Mortality

FRIDAY, April 16, 2021 -- COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE. Vijay M....

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.